We are dedicated to developing and commercializing innovative vaccines that modulate the immune system to prevent disease.

About Dynavax Technologies

Dynavax Technologies Corporation (Nasdaq: DVAX) is a fully-integrated biopharmaceutical company focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation. Dynavax develops, and commercializes novel vaccines.

We are committed to a rigorous approach to drug development in the field of TLR biology so that we may help physicians and patients address unmet needs. Our vision and work ethic are guided by the collective ideals underpinning our corporate values, and these form the basis of our company culture.

Management Team

Our management team is comprised of industry veterans that have extensive expertise in drug development and commercialization. With experience spanning successful biopharmaceutical companies to pertinent government organizations, they bring a rich knowledge-base to lead a growing fast-paced company.

 

steven gersten photo

Steven N. Gersten

Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Secretary

robert janssen photo

Robert Janssen

Chief Medical Officer and Senior Vice President, Clinical Development

david novack photo

David Novack

Senior Vice President, Operations and Quality, CO-PRESIDENT

michael ostrach photo

Michael S. Ostrach

Senior Vice President, Chief Financial Officer and Chief Business Officer

ryan spencer photo

Ryan Spencer

SENIOR VICE PRESIDENT OF COMMERCIAL, CO-PRESIDENT

jeff coon photo

Jeff Coon

Senior Vice President, Human Resources and Corporate Services

Board of Directors

Our Board of Directors is a pedigreed group with broad leadership backgrounds. Their current and previous roles as biotech executives, physicians, researchers, and investors provides us with multifaceted expertise to help us reach our shared vision for helping patients. 

 

Dynavax Europe

Dynavax GmbH (Dynavax Europe), is the European affiliate of Dynavax Technologies Corporation. For more than 25 years, we have been dedicated to the development and manufacturing of vaccines and biopharmaceuticals.

Learn More